Leen Rigouts

9.6k total citations
172 papers, 4.3k citations indexed

About

Leen Rigouts is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Leen Rigouts has authored 172 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Infectious Diseases, 153 papers in Epidemiology and 55 papers in Surgery. Recurrent topics in Leen Rigouts's work include Tuberculosis Research and Epidemiology (157 papers), Mycobacterium research and diagnosis (135 papers) and Diagnosis and treatment of tuberculosis (33 papers). Leen Rigouts is often cited by papers focused on Tuberculosis Research and Epidemiology (157 papers), Mycobacterium research and diagnosis (135 papers) and Diagnosis and treatment of tuberculosis (33 papers). Leen Rigouts collaborates with scholars based in Belgium, France and United States. Leen Rigouts's co-authors include Bouke C. de Jong, Françoise Portaels, Armand Van Deun, Isdore Chola Shamputa, Pim de Rijk, Conor J. Meehan, Willem Bram de Rijk, I. Bastian, K. J. M. Aung and Mourad Gumusboga and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Leen Rigouts

162 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leen Rigouts Belgium 37 3.7k 3.5k 1.6k 717 356 172 4.3k
Doris Hillemann Germany 32 3.9k 1.0× 3.5k 1.0× 1.9k 1.2× 1.0k 1.4× 315 0.9× 87 5.0k
Beverly Metchock United States 28 3.0k 0.8× 2.6k 0.8× 1.3k 0.8× 589 0.8× 475 1.3× 53 3.7k
Sofía Samper Spain 30 3.3k 0.9× 3.1k 0.9× 1.6k 1.0× 633 0.9× 267 0.8× 86 3.9k
Véronique Vincent France 27 2.9k 0.8× 2.9k 0.8× 1.4k 0.9× 537 0.7× 167 0.5× 55 3.7k
Elvira Richter Germany 42 3.8k 1.0× 3.9k 1.1× 1.8k 1.1× 575 0.8× 236 0.7× 129 5.0k
Sven Hoffner Sweden 32 2.7k 0.7× 2.4k 0.7× 1.0k 0.7× 556 0.8× 356 1.0× 81 3.0k
Nicolas Véziris France 32 2.7k 0.7× 2.7k 0.8× 760 0.5× 784 1.1× 441 1.2× 139 3.5k
Bouke C. de Jong Belgium 38 5.2k 1.4× 4.7k 1.4× 2.3k 1.5× 1.1k 1.5× 387 1.1× 192 6.1k
Sjoukje Kuijper Netherlands 25 3.3k 0.9× 3.2k 0.9× 1.9k 1.2× 525 0.7× 129 0.4× 43 4.0k
Bonnie B. Plikaytis United States 29 3.0k 0.8× 2.8k 0.8× 1.3k 0.8× 977 1.4× 370 1.0× 50 3.8k

Countries citing papers authored by Leen Rigouts

Since Specialization
Citations

This map shows the geographic impact of Leen Rigouts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leen Rigouts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leen Rigouts more than expected).

Fields of papers citing papers by Leen Rigouts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leen Rigouts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leen Rigouts. The network helps show where Leen Rigouts may publish in the future.

Co-authorship network of co-authors of Leen Rigouts

This figure shows the co-authorship network connecting the top 25 collaborators of Leen Rigouts. A scholar is included among the top collaborators of Leen Rigouts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leen Rigouts. Leen Rigouts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souleymane, Mahamadou Bassirou, Tom Decroo, Eric Adéhossi, et al.. (2025). Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB. PubMed. 2(8). 450–458.
2.
Gasana, Janvier, Tom Decroo, Bart K. M. Jacobs, et al.. (2025). High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial. PubMed. 2(11). 655–661.
3.
4.
Laryea, Ruth, et al.. (2024). Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB. SHILAP Revista de lepidopterología. 1(7). 306–313. 2 indexed citations
5.
Guyeux, Christophe, Philip Supply, Cyril Gaudin, et al.. (2024). Newly Identified Mycobacterium africanum Lineage 10, Central Africa. Emerging infectious diseases. 30(3). 560–563. 19 indexed citations
6.
Mulders, Wim, Matthias Merker, Stefan Niemann, et al.. (2024). Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology Spectrum. 12(3). e0007024–e0007024. 9 indexed citations
7.
Lempens, Pauline, Armand Van Deun, K. J. M. Aung, et al.. (2023). Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh. Microbial Genomics. 9(9).
8.
Souleymane, Mahamadou Bassirou, Tom Decroo, Saïdou Mamadou, et al.. (2022). Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study. International Health. 15(3). 258–264. 2 indexed citations
9.
Mansjö, Mikael, et al.. (2022). Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study. Antimicrobial Agents and Chemotherapy. 66(6). e0207521–e0207521. 8 indexed citations
10.
Cornet, Luc, Ilse Cleenwerck, Heide‐Marie Daniel, et al.. (2022). The GEN-ERA toolbox: unified and reproducible workflows for research in microbial genomics. GigaScience. 12. 5 indexed citations
11.
Meehan, Conor J., et al.. (2021). Reconstituting the genus Mycobacterium. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 71(9). 51 indexed citations
12.
Coscollá, Mireia, Boatema Ofori-Anyinam, Isaac Darko Otchere, et al.. (2021). Mycobacterium tuberculosis complex lineage 5 exhibits high levels of within-lineage genomic diversity and differing gene content compared to the type strain H37Rv. Microbial Genomics. 7(7). 12 indexed citations
13.
Loiseau, Chloé, Fabrizio Menardo, Abraham Aseffa, et al.. (2020). An African origin for Mycobacterium bovis. Evolution Medicine and Public Health. 2020(1). 49–59. 36 indexed citations
14.
Battaglia, Simone, Andrea Spitaleri, Andrea Maurizio Cabibbe, et al.. (2020). Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains. Journal of Clinical Microbiology. 58(11). 41 indexed citations
15.
Jong, Bouke C. de, et al.. (2019). Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing. Journal of Clinical Microbiology. 57(7). 2 indexed citations
16.
Torrea, Gabriela, Armand Van Deun, Emmanuel André, et al.. (2019). Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Scientific Reports. 9(1). 11826–11826. 33 indexed citations
17.
Affolabi, Dissou, et al.. (2017). Genotypic characterization directly applied to sputum improves the detection of Mycobacterium africanum West African 1, under-represented in positive cultures. PLoS neglected tropical diseases. 11(9). e0005900–e0005900. 24 indexed citations
18.
Thys, É., et al.. (2011). La tuberculose à Mycobacterium bovis en Afrique subsaharienne. Annales de médecine vétérinaire. 155(1). 23–37. 9 indexed citations
19.
Shamputa, Isdore Chola, Leen Rigouts, Anne Dediste, et al.. (2007). Molecular investigation of recurrent tuberculosis in patients from Rwanda.. PubMed. 11(8). 860–7. 17 indexed citations
20.
Rigouts, Leen, et al.. (2007). Résistance primaire et acquise aux antituberculeux des souches de Mycobacterium tuberculosis isolées au Rwanda. 67(2). 149–153. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris Hillemann Breakdown of academic impact, for papers by Beverly Metchock Breakdown of academic impact, for papers by Sofía Samper Breakdown of academic impact, for papers by Véronique Vincent Breakdown of academic impact, for papers by Elvira Richter Breakdown of academic impact, for papers by Sven Hoffner Breakdown of academic impact, for papers by Nicolas Véziris Breakdown of academic impact, for papers by Bouke C. de Jong Breakdown of academic impact, for papers by Sjoukje Kuijper Breakdown of academic impact, for papers by Bonnie B. Plikaytis
Rankless by CCL
2026